Epidemiological data from the registry of patients with myelodysplastic syndrome in a single hospital center of Romania

Leukemia Research

Volumn 33, Issue 11, 2009, Pages 1556-1561

  Gologan, Radu ^a   Georgescu, Daniela ^a   Tatic, Aurelia ^a   Radulescu, Ioana ^a   Vasilache, Didona ^a  

^a FUNDENI CLINICAL INSTITUTE   (Romania)

Author keywords

Epidemiology; Myelodysplastic syndrome

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CHINA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; GERMANY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; ROMANIA; SEX RATIO; SPAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; REGISTRIES; ROMANIA;

EID: 68649084420     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.03.034     Document Type: Article

References (41)

1. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51 (1982) 189-199
2. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Int Med 103 (1985) 620-625
3. Germing U., Strupp C., Kündgen A., et al. No increase in age-specific incidence of myelodysplastic syndromes. Haematologica 89 (2004) 905-910
4. Aul C., Giagounidis A., and Germing U. Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statistics. Int J Hematol 73 (2001) 405-410
5. Strom S.S., Gu Y., Gruschkus S.K., Pierce S.A., and Estey E.H. Risk factors of myelodysplastic syndromes: a case control study. Leukemia 19 (2005) 1912-1918
6. Sanz G.F., Sanz M.A., Vallespi T., et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 74 (1989) 409-415
7. Iglesias Gallego M., Moral Sastre J.L., Diz P.G., Costa A.G., Forteza S.R., and Santos Mayan J.M. Incidence and characteristics of myelodysplastic syndromes in Ourense (Spain) between 1994-1998. Haematologica 88 (2003) 1197-1199
8. Chen B., Zhao W.-L., Jin J., et al. Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries. Leukemia 19 (2005) 767-775
9. Harris N.L., Jaffe E.S., Diebold J., et al. World Health Organization of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting-Arlie House, Virginia, November 1997. J Clin Oncol 17 (1999) 3835-3849
10. Rollison D.E., Hayat M., Smith M., et al. First report of national estimates of the incidence of myelodysplastic syndromes and chronic myeloproliferative disorders from the U.S. SEER Program. The 48th ASH Meeting. Orlando (Florida) (2006) Abstract #247
11. Rollison D.E., Howlader N., Smith M.T., et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood 112 (2008) 45-52
12. Bari A, Marcheselli R, Rashid I, et al. Incidence and outcome of myelodysplastic syndromes in province of Modena. The 49th ASH Annual Meeting, Atlanta (Georgia), 2007, Abstract #4610.
13. Aul C., Germing U., Gattermann N., and Minning H. Increasing incidence of myelodysplastic syndromes: real or fictitious?. Leuk Res 22 (1998) 93-100
14. Greenberg P.L. Myelodysplastic syndromes. Clinical and biological advances (2006), Cambridge University Press p. 81
15. Nisse C., Haguenoer J.M., Grandbastien B., et al. Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France. Br J Haematol 112 (2001) 927-935
16. Maynadie M., Verret C., Moskovtchenko P., et al. Epidemiological characteristics of myelodysplastic syndromes in a well-defined French population. Br J Cancer 74 (1996) 288-290
17. Bauduer F., Ducout L., Dastugue N., Capdupuy C., and Renoux M. Epidemiology of myelodysplastic syndromes in French population. Br J Cancer 22 (1998) 205-208
18. Salvi F., Gatto S., Biale L., et al. Epidemiological survey on myelodysplastic syndromes (MDS) in Piedmont, Italy: preliminary evaluation of transfusional requirements based on Piedmont MDS register website. The 8th international symposium on MDS. Nagasaki (Japan) (2005) Abstract #P-78
19. Williamson P.J., Kruger A.R., Reynolds P.J., Hamblin T.J., and Oscier D.G. Establishing the incidence of myelodysplastic syndrome. Br J Haematol 87 (1994) 743-745
20. Radlund A., Thiede T., Hansen S., Carlsson M., and Engquist L. Incidence of myelodysplastic syndromes in a Swedish population. Eur J Haematol 54 (1995) 153-156
21. Matacia-Murphy GM, Al Ali NH, Schrager JA, Beg MS, Safa MM, Komrokji RS. Myelodysplastic syndrome: a study of VA population. The 49th ASH Annual Meeting, Atlanta (Georgia), 2007, Abstract #2470.
22. Ma X., Does M., Raza A., and Mayne S.T. Myelodysplastic syndromes: incidence and survival in the United States. Cancer 109 (2007) 1536-1542
23. Goldberg S.L., Mody-Patel N., and Warnock N. Incidence of myelodysplastic syndromes in the United States Medicare population. The 9th international symposium on myelodysplastic syndromes. Florence (Italy) (2007) Abstract #P001
24. Oguma S., Yoshida Y., Uchino H., Maekawa T., and Mizogushi H. Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a cooperative study based on 838 cases. Leuk Res 19 (1995) 219-225
25. Matsuda A., Germing U., Jinnai I., et al. Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes. Blood 106 (2005) 2633-2640
26. Zhao W.L., Xu L., Wu W., et al. The myelodysplastic syndromes: analysis of prognostic factors and comparison of prognostic systems in 128 Chinese patients from a single institution. Hematol J 3 (2002) 137-144
27. Irons R.D., Wang X., Gross S.A., et al. Prevalence of MDS subtypes in Shanghai, China: a comparison of the World Health Organization and French American British classifications. Leuk Res 30 (2006) 769-775
28. Intragumtornchai W.T., Prayoonwiwat D., Swasdikul N., et al. Myelodysplastic syndromes in Thailand: a retrospective pathologic and clinical analysis of 117 cases. Leuk Res 22 (1998) 453-460
29. Lee D.S., Kim S.H., Seo E.J., et al. Predominance of trisomy 1q in myelodysplastic syndromes in Korea: is there an ethnic difference? A 3-year multi-center study. Cancer Genet Cytogenet 132 (2002) 97-101
30. Lee J.H., Lee J.H., Shin Y.R., et al. Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome. Leukemia 17 (2003) 305-313
31. Paydas S., and Kokak R. Younger age observation in myelodysplastic syndrome. Leuk Res 20 (1996) 367
32. Mukiibi J.M., and Paul B. Myelodysplastic syndrome (MDS) in Central Africans. Trop Geogr Med 46 (1994) 17-19
33. Dakshinamurthy A.G., Novitzky N., Bharadwaj R., and Prakhhya B.M. Cytogenetic analysis of 52 Indian patients with de novo myelodysplastic syndromes-a comparative analysis of results with reports from Asia. Ann Hematol 84 (2005) 298-303
34. Lorand-Metze I., Pinheiro M.P., Ribeiro E., de Paula E.V., and Metze K. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Leuk Res 28 (2004) 587-594
35. Belli C., Acevedo S., Bengio R., Arrossagaray G., Watman N., and Rossi N. Detection of risk groups in myelodysplastic syndromes. A multicenter study. Haematologica 87 (2002) 9-16
36. Lau L.G., Chng W.J., Liu T.C., et al. Clinico-patological analysis of myelodysplastic syndromes according to French-American-British classification and International Prognostic Scoring Systems. Ann Acad Med Singapore 33 (2004) 589-595
37. Paydas S. Young age MDS: differences between Western and Eastern countries. Leuk Res 30 (2006) 362 (letter)
38. Kuendgen A., Matsuda A., and Germing U. Differences in epidemiology of MDS between Western and Eastern countries: ethnic differences or environmental influence?. Leuk Res (2007) 103-104
39. Breccia M., Mengarelli A., Mancini M., et al. Myelodysplastic syndromes in patients under 50 years old: a single institution experience. Leuk Res 29 (2005) 749-754
40. Catenacci D., and Schiller G.J. Myelodysplastic syndromes: a comprehensive review. Blood Rev 19 (2005) 301-319
41. Shimizu H., Matsushita Y., Aoki K., Nomura T., Yoshida Y., and Mizoguchi H. Prevalence of the myelodysplastic syndromes in Japan. Int J Hamatol 61 (1995) 17-22